452 related articles for article (PubMed ID: 20858595)
1. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
[TBL] [Abstract][Full Text] [Related]
2. A centronuclear myopathy--dynamin 2 mutation impairs autophagy in mice.
Durieux AC; Vassilopoulos S; Lainé J; Fraysse B; Briñas L; Prudhon B; Castells J; Freyssenet D; Bonne G; Guicheney P; Bitoun M
Traffic; 2012 Jun; 13(6):869-79. PubMed ID: 22369075
[TBL] [Abstract][Full Text] [Related]
3. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
Tinelli E; Pereira JA; Suter U
Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
[TBL] [Abstract][Full Text] [Related]
4. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
[TBL] [Abstract][Full Text] [Related]
6. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.
Susman RD; Quijano-Roy S; Yang N; Webster R; Clarke NF; Dowling J; Kennerson M; Nicholson G; Biancalana V; Ilkovski B; Flanigan KM; Arbuckle S; Malladi C; Robinson P; Vucic S; Mayer M; Romero NB; Urtizberea JA; García-Bragado F; Guicheney P; Bitoun M; Carlier RY; North KN
Neuromuscul Disord; 2010 Apr; 20(4):229-37. PubMed ID: 20227276
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
[TBL] [Abstract][Full Text] [Related]
8. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.
Bitoun M; Bevilacqua JA; Prudhon B; Maugenre S; Taratuto AL; Monges S; Lubieniecki F; Cances C; Uro-Coste E; Mayer M; Fardeau M; Romero NB; Guicheney P
Ann Neurol; 2007 Dec; 62(6):666-70. PubMed ID: 17932957
[TBL] [Abstract][Full Text] [Related]
9. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement.
Schessl J; Medne L; Hu Y; Zou Y; Brown MJ; Huse JT; Torigian DA; Jungbluth H; Goebel HH; Bönnemann CG
Neuromuscul Disord; 2007 Jan; 17(1):28-32. PubMed ID: 17134899
[TBL] [Abstract][Full Text] [Related]
10. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
[TBL] [Abstract][Full Text] [Related]
11. Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis.
Bitoun M; Durieux AC; Prudhon B; Bevilacqua JA; Herledan A; Sakanyan V; Urtizberea A; Cartier L; Romero NB; Guicheney P
Hum Mutat; 2009 Oct; 30(10):1419-27. PubMed ID: 19623537
[TBL] [Abstract][Full Text] [Related]
12. Mutations in dynamin 2 cause dominant centronuclear myopathy.
Bitoun M; Maugenre S; Jeannet PY; Lacène E; Ferrer X; Laforêt P; Martin JJ; Laporte J; Lochmüller H; Beggs AH; Fardeau M; Eymard B; Romero NB; Guicheney P
Nat Genet; 2005 Nov; 37(11):1207-9. PubMed ID: 16227997
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
[TBL] [Abstract][Full Text] [Related]
14. Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathy.
Fraysse B; Guicheney P; Bitoun M
Biol Open; 2016 Nov; 5(11):1691-1696. PubMed ID: 27870637
[TBL] [Abstract][Full Text] [Related]
15. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.
Melberg A; Kretz C; Kalimo H; Wallgren-Pettersson C; Toussaint A; Böhm J; Stålberg E; Laporte J
Neuromuscul Disord; 2010 Jan; 20(1):53-6. PubMed ID: 19932619
[TBL] [Abstract][Full Text] [Related]
16. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
[TBL] [Abstract][Full Text] [Related]
17. Centronuclear myopathies: a widening concept.
Romero NB
Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.
Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J
Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436
[TBL] [Abstract][Full Text] [Related]
19. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
[TBL] [Abstract][Full Text] [Related]
20. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]